Innovent Biologics (01801.HK) Announces Changes in Issued Shares

Bulletin Express12-05

Innovent Biologics, Inc. (stock code: 01801) released a Next Day Disclosure Return dated 5 December 2025, reporting changes in its issued shares. As of 30 November 2025, the company had 1,713,863,236 issued shares. The changes took place on 3 and 4 December 2025.

On 3 December 2025, 17,143 ordinary shares were allotted and issued at HKD 78.2 per share pursuant to the exercise of share options under the Post-IPO ESOP adopted on 12 June 2018. On 4 December 2025, a further 6,857 shares were allotted and issued at HKD 78.2 per share under the same scheme. Additionally, 6,913,834 new ordinary shares were allotted and issued at HKD 112.56 per share upon completion of a subscription disclosed in announcements dated 22 October 2025 and 5 December 2025.

Following these allotments and issues, Innovent Biologics’ total issued share capital increased to 1,720,801,070 ordinary shares as of 4 December 2025. No share repurchases or redemptions were reported.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155507620?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-05 07:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155507620","market":"hk","top_or_hot":-1,"title":"Innovent Biologics (01801.HK) Announces Changes in Issued Shares","media":"Bulletin Express","content":"<p>Innovent Biologics, Inc. (stock code: 01801) released a Next Day Disclosure Return dated 5 December 2025, reporting changes in its issued shares. As of 30 November 2025, the company had 1,713,863,236 issued shares. The changes took place on 3 and 4 December 2025.</p>\n<p>On 3 December 2025, 17,143 ordinary shares were allotted and issued at HKD 78.2 per share pursuant to the exercise of share options under the Post-IPO ESOP adopted on 12 June 2018. On 4 December 2025, a further 6,857 shares were allotted and issued at HKD 78.2 per share under the same scheme. Additionally, 6,913,834 new ordinary shares were allotted and issued at HKD 112.56 per share upon completion of a subscription disclosed in announcements dated 22 October 2025 and 5 December 2025.</p>\n<p>Following these allotments and issues, Innovent Biologics’ total issued share capital increased to 1,720,801,070 ordinary shares as of 4 December 2025. No share repurchases or redemptions were reported.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Innovent Biologics (01801.HK) Announces Changes in Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnovent Biologics (01801.HK) Announces Changes in Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-05 07:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Innovent Biologics, Inc. (stock code: 01801) released a Next Day Disclosure Return dated 5 December 2025, reporting changes in its issued shares. As of 30 November 2025, the company had 1,713,863,236 issued shares. The changes took place on 3 and 4 December 2025.</p>\n<p>On 3 December 2025, 17,143 ordinary shares were allotted and issued at HKD 78.2 per share pursuant to the exercise of share options under the Post-IPO ESOP adopted on 12 June 2018. On 4 December 2025, a further 6,857 shares were allotted and issued at HKD 78.2 per share under the same scheme. Additionally, 6,913,834 new ordinary shares were allotted and issued at HKD 112.56 per share upon completion of a subscription disclosed in announcements dated 22 October 2025 and 5 December 2025.</p>\n<p>Following these allotments and issues, Innovent Biologics’ total issued share capital increased to 1,720,801,070 ordinary shares as of 4 December 2025. No share repurchases or redemptions were reported.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01801","symbol_name":"信达生物","start_time":0,"source_url":"","article_id":"1155507620","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155507620","pubTimestamp":1764889488,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Innovent Biologics, Inc. (stock code: 01801) released a Next Day Disclosure Return dated 5 December 2025, reporting changes in its issued shares. As of 30 November 2025, the company had 1,713,863,236...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01801":"信达生物"},"translate_title":"信达生物(01801.HK)公布已发行股份变动","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01801":1},"content_text":"Innovent Biologics, Inc. (stock code: 01801) released a Next Day Disclosure Return dated 5 December 2025, reporting changes in its issued shares. As of 30 November 2025, the company had 1,713,863,236 issued shares. The changes took place on 3 and 4 December 2025.\nOn 3 December 2025, 17,143 ordinary shares were allotted and issued at HKD 78.2 per share pursuant to the exercise of share options under the Post-IPO ESOP adopted on 12 June 2018. On 4 December 2025, a further 6,857 shares were allotted and issued at HKD 78.2 per share under the same scheme. Additionally, 6,913,834 new ordinary shares were allotted and issued at HKD 112.56 per share upon completion of a subscription disclosed in announcements dated 22 October 2025 and 5 December 2025.\nFollowing these allotments and issues, Innovent Biologics’ total issued share capital increased to 1,720,801,070 ordinary shares as of 4 December 2025. No share repurchases or redemptions were reported.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155507620","isCrawlerRequest":true}